These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37857014)

  • 21. Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling.
    Li T; Li S; Feng Y; Zeng X; Dong S; Li J; Zha L; Luo H; Zhao L; Liu B; Ou Z; Lin W; Zhang M; Li S; Jiang Q; Qi Q; Xu Q; Yu Z
    Oxid Med Cell Longev; 2020; 2020():6973636. PubMed ID: 32617141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Krüppel-like Factor 7 inhibits proliferation and migration of pulmonary smooth muscle cells via p21 activation.
    Zeng Z; Zhou X; Zhu Y; Huang X; Tong X; Liu J; Zhang T; Wu W
    Eur J Pharmacol; 2023 Feb; 940():175473. PubMed ID: 36566916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
    Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y
    Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
    Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
    Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salusin-β, a TOR2A gene product, promotes proliferation, migration, fibrosis, and calcification of smooth muscle cells and accelerates the imbalance of vasomotor function and vascular remodeling in monocrotaline-induced pulmonary hypertensive rats.
    Wang X; Chen A; Hu R; Zhang F; Liang S; Bao C; Liu X; Tang H; Han Y
    Front Pharmacol; 2022; 13():928834. PubMed ID: 36249810
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroRNA-140-5p targeting tumor necrosis factor-α prevents pulmonary arterial hypertension.
    Zhu TT; Zhang WF; Yin YL; Liu YH; Song P; Xu J; Zhang MX; Li P
    J Cell Physiol; 2019 Jun; 234(6):9535-9550. PubMed ID: 30367500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.
    Liu C; Wan N; Wei L; Rong W; Zhu W; Xie M; Zhang Y; Liu Z; Jing Q; Lyu A
    Vascul Pharmacol; 2023 Dec; 153():107233. PubMed ID: 37742818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the p62-Keap1-Nrf2 pathway improves pulmonary arterial hypertension in MCT-induced rats by inhibiting autophagy.
    Jiang G; Shi LF; Li LJ; Duan XJ; Zheng ZF
    FASEB J; 2024 Feb; 38(3):e23452. PubMed ID: 38308640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy.
    Ma C; Xu Q; Huang S; Song J; Sun M; Zhang J; Chu G; Zhang B; Bai Y; Zhao X; Wang Z; Li P
    FASEB J; 2023 May; 37(5):e22906. PubMed ID: 37052859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease in Tripartite Motif Containing 24 suppresses hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/mammalian target of rapamycin complex 1 pathway.
    Xu J; Zhong Y; Wang Z
    Bioengineered; 2022 May; 13(5):13596-13606. PubMed ID: 35653796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.
    Bao C; He Q; Wang H; Sun Y; Xu Y; Pan Y; Hu Y; Zheng S; Liang S; Luo A; Nahar T; Chen J; Tang H; Han Y
    Oxid Med Cell Longev; 2022; 2022():2782429. PubMed ID: 35757500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
    Yang HT; Wang G; Zhu PC; Xiao ZY
    Exp Cell Res; 2023 May; 426(1):113555. PubMed ID: 36921705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obstructive sleep apnea-increased DEC1 regulates systemic inflammation and oxidative stress that promotes development of pulmonary arterial hypertension.
    Li X; Zhang X; Hou X; Bing X; Zhu F; Wu X; Guo N; Zhao H; Xu F; Xia M
    Apoptosis; 2023 Apr; 28(3-4):432-446. PubMed ID: 36484960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.
    Su H; Zhu H; Wang S; Li Y; Yan C; Wang J; Ying K
    Respir Res; 2023 Jun; 24(1):165. PubMed ID: 37344798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TIGAR reduces smooth muscle cell autophagy to prevent pulmonary hypertension.
    Yamanaka R; Hoshino A; Fukai K; Urata R; Minami Y; Honda S; Fushimura Y; Hato D; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1087-H1096. PubMed ID: 32946259
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancer of zeste homolog 2 induces pulmonary artery smooth muscle cell proliferation.
    Aljubran SA; Cox R; Tamarapu Parthasarathy P; Kollongod Ramanathan G; Rajanbabu V; Bao H; Mohapatra SS; Lockey R; Kolliputi N
    PLoS One; 2012; 7(5):e37712. PubMed ID: 22662197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.